Scoping Out Optimal Antiviral Therapy for Patients With COVID-19: Exploring the Implications of the Latest Data
Going Below the Surface in Advanced Basal Cell Carcinoma: Analysing the Latest Evidence
Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?